Aireen specializes in AI detection of chronic diseases from retina, offering a medical device with autonomous capabilities and fast diagnostic results.

Aireen

Aireen | 1,956 followers on LinkedIn. AI-driven precision screening for better healthcare outcomes—early detection, improved efficiency, and empowered care. | Aireen is an innovative AI-powered medical device dedicated to transforming how healthcare providers detect and manage serious diseases. By leveraging advanced neural network models, Aireen enables autonomous, precise screening for conditions such as diabetic retinopathy (DR), age-related macular degeneration (AMD), cardiovascular diseases, and neurodegenerative disorders.

Why Aireen?

Founder/General Partner at Tensor Ventures

Martin Drdul

Business development

Adam Švrčina

CEO, Digital health expert, KOL, AI and Big Data advocate. Experienced business leader on a mission to improve systems of healthcare.

Matej Adam

Founder and CEO ve společnosti Oční klinika NeoVize

Petr Kocian

𝗝𝗼𝗶𝗻 𝗔𝗶𝗿𝗲𝗲𝗻 𝗮𝘁 𝗠𝗲𝗱𝗶𝗰𝗮 𝟮𝟬𝟮𝟰 𝗶𝗻 𝗗𝘂𝘀𝘀𝗲𝗹𝗱𝗼𝗿𝗳! We’re thrilled to announce that Aireen will be exhibiting at Medica, the world’s leading medical trade fair, from 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟭𝟭-𝟭𝟰, 2024 in Düsseldorf, Germany. Stop by our booth to discover how Aireen’s AI-driven technology is transforming diabetic retinopathy screening and expanding into new health diagnostics, including AMD and cardiovascular assessments. Learn how our solutions can benefit healthcare providers, improve patient outcomes, and offer unique partnership opportunities. 𝗗𝗼𝗻’𝘁 𝗺𝗶𝘀𝘀 𝘁𝗵𝗲 𝗰𝗵𝗮𝗻𝗰𝗲 𝘁𝗼 𝗲𝘅𝗽𝗹𝗼𝗿𝗲 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻 𝗽𝗼𝘀𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝗶𝗲𝘀 𝗮𝗻𝗱 𝘀𝗲𝗲 𝗼𝘂𝗿 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 𝗶𝗻 𝗮𝗰𝘁𝗶𝗼𝗻! We look forward to meeting you there and discussing how we can work together to drive innovation in healthcare.

🌍 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝘁𝗵𝗲 𝗖𝘇𝗲𝗰𝗵 𝗥𝗲𝗽𝘂𝗯𝗹𝗶𝗰 𝗮𝗻𝗱 𝗔𝗶𝗿𝗲𝗲𝗻’𝘀 𝗥𝗼𝗹𝗲 🌍 The Czech Republic has a strong interest in innovation, as shown by this year's CSOB Innovation Index, which scored 78.3 points. Alongside experts, we joined the discussion on the survey results and shared insights on how innovations are making a real impact. 💡 𝗞𝗲𝘆 𝗙𝗶𝗻𝗱𝗶𝗻𝗴𝘀: ✅ 90% of Czechs appreciate innovations that simplify daily life, especially in areas like cashless payments, online entertainment, and AI applications. 🔼 There is still room for improvement in healthcare and public services, with people hoping for more efficient digitalization and modern infrastructure. ⚙️ Czech startups are the driving force behind innovation, with many already fully utilizing the potential of artificial intelligence. At Aireen, we believe that innovation has the power to transform lives – which is why we focus on cutting-edge technology to enhance healthcare. Our goal is to ensure innovations are truly beneficial for everyone. Together, we’re working to make healthcare simpler, more accessible, and more accurate through AI. ➡️ 𝗟𝗲𝘁’𝘀 𝗵𝗮𝗿𝗻𝗲𝘀𝘀 𝘁𝗵𝗲 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗼𝗳 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝘁𝗼 𝗶𝗺𝗽𝗿𝗼𝘃𝗲 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗼𝗳 𝗹𝗶𝗳𝗲 𝗳𝗼𝗿 𝗮𝗹𝗹! Matej Adam Michaela Bauer Matěj Misař Jan Hlaváček Jana Lvova Adam Švrčina

𝗧𝗵𝗲 𝗗𝗶𝗮𝗯𝗲𝘁𝗲𝘀 𝗖𝗿𝗶𝘀𝗶𝘀 𝗶𝘀 𝗚𝗿𝗼𝘄𝗶𝗻𝗴—𝗜𝘀 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗥𝗲𝗮𝗱𝘆? With over 537 million adults currently living with diabetes, that number is set to soar to 783 million by 2045. Even more alarming, 𝟯𝟬% 𝗼𝗳 𝗱𝗶𝗮𝗯𝗲𝘁𝗶𝗰 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗮𝗿𝗲 𝗮𝘁 𝗿𝗶𝘀𝗸 𝗼𝗳 𝗱𝗶𝗮𝗯𝗲𝘁𝗶𝗰 𝗿𝗲𝘁𝗶𝗻𝗼𝗽𝗮𝘁𝗵𝘆 (DR), leading to vision loss if not detected early. 📊 As the diabetic population expands, healthcare systems are facing an 𝘂𝗿𝗴𝗲𝗻𝘁 𝗻𝗲𝗲𝗱 𝗳𝗼𝗿 𝗲𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝘁, 𝘀𝗰𝗮𝗹𝗮𝗯𝗹𝗲 𝘀𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀. This is where Aireen steps in. Powered by cutting-edge AI, Aireen autonomously screens for DR, reducing the burden on overworked medical staff while improving 𝗲𝗮𝗿𝗹𝘆 𝗱𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 𝗿𝗮𝘁𝗲𝘀. 💡 𝗧𝗵𝗲 𝗽𝗿𝗼𝗷𝗲𝗰𝘁𝗲𝗱 𝗴𝗿𝗼𝘄𝘁𝗵 𝗶𝗻 𝗱𝗶𝗮𝗯𝗲𝘁𝗲𝘀 𝗮𝗻𝗱 𝗗𝗥 𝗵𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗮 𝗺𝗮𝘀𝘀𝗶𝘃𝗲 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆 𝗳𝗼𝗿 𝗔𝗜-𝗱𝗿𝗶𝘃𝗲𝗻 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝗲𝗻𝗵𝗮𝗻𝗰𝗲 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗼𝘂𝘁𝗰𝗼𝗺𝗲𝘀 𝗮𝗻𝗱 𝗹𝗼𝘄𝗲𝗿 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗰𝗼𝘀𝘁𝘀. By integrating Aireen into routine practice, clinics and hospitals can scale screening efforts, deliver faster diagnoses, and meet the rising demand for proactive care. 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹? With the global diabetic population on the rise, there’s never been a more crucial time to invest in technology that empowers healthcare systems to keep pace. 𝗥𝗲𝗮𝗱𝘆 𝘁𝗼 𝘀𝗲𝗲 𝗵𝗼𝘄 𝗔𝗶𝗿𝗲𝗲𝗻 𝗰𝗮𝗻 𝗿𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗶𝘇𝗲 𝘆𝗼𝘂𝗿 𝗽𝗿𝗮𝗰𝘁𝗶𝗰𝗲? 𝗟𝗲𝘁’𝘀 𝗰𝗼𝗻𝗻𝗲𝗰𝘁! #HealthcareInnovation #DiabetesCare #AIinHealthcare #Aireen #RetinaScreening #FutureofHealthcare

Aireen appeared on TV! 👁 🔥 A big thank you to Víkend ( TV Nova ) for featuring our software Aireen. Aireen already helps with the non-invasive detection of eye diseases in real-world settings. Together with colleagues David Navratil , Jan Bayer and Petra Králová , we explained why the application of #AI in #healthcare is beneficial and meaningful. Our goal is not to replace physicians but to provide them with efficient support. We are very grateful for the opportunity! 🔥 And what more could you wish for than to be presented by Lucie Borhyová! 😊

Kamila Dvořák (Lepková)

We are thrilled to see Aireen featured on TV show Víkend by TV NOVA. Our mission is to empower healthcare professionals with cutting-edge AI tools that make non-invasive detection of eye diseases more accessible and effective. It was a pleasure for our talented team— Kamila Dvořák (Lepková) , David Navratil , Jan Bayer , and Petra Králová —to share insights into how Aireen supports clinicians, ensuring better care for patients. Together, we are shaping the future of AI in healthcare. 🔥 #AIinHealthcare #Aireen #EyeHealth #NonInvasive #AI

🌟 Happy Monday! 𝗟𝗲𝘁'𝘀 𝗸𝗶𝗰𝗸 𝗼𝗳𝗳 𝘁𝗵𝗲 𝘄𝗲𝗲𝗸 𝘄𝗶𝘁𝗵 𝘀𝗼𝗺𝗲 𝗶𝗺𝗽𝗮𝗰𝘁! 🌟 Did you know that diabetic retinopathy is the leading cause of vision loss among adults globally? 𝗘𝗮𝗿𝗹𝘆 𝗱𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 𝗶𝘀 𝗰𝗿𝘂𝗰𝗶𝗮𝗹, but many healthcare systems face challenges in providing timely and efficient screening. That's where Aireen DR comes in. 💡 𝗔𝘀 𝗮𝗻 𝗮𝘂𝘁𝗼𝗻𝗼𝗺𝗼𝘂𝘀 𝗖𝗹𝗮𝘀𝘀 𝗜𝗜𝗯 𝘀𝗼𝗳𝘁𝘄𝗮𝗿𝗲, 𝗔𝗶𝗿𝗲𝗲𝗻 𝗲𝗺𝗽𝗼𝘄𝗲𝗿𝘀 𝗹𝗼𝘄𝗲𝗿 𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝘀𝘁𝗮𝗳𝗳 𝘁𝗼 𝗰𝗼𝗻𝗱𝘂𝗰𝘁 𝗱𝗶𝗮𝗯𝗲𝘁𝗶𝗰 𝗿𝗲𝘁𝗶𝗻𝗼𝗽𝗮𝘁𝗵𝘆 𝘀𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴𝘀 𝗶𝗻𝗱𝗲𝗽𝗲𝗻𝗱𝗲𝗻𝘁𝗹𝘆, 𝘄𝗶𝘁𝗵𝗼𝘂𝘁 𝘁𝗵𝗲 𝗻𝗲𝗲𝗱 𝗳𝗼𝗿 𝗮 𝗱𝗼𝗰𝘁𝗼𝗿 𝘁𝗼 𝗲𝘃𝗮𝗹𝘂𝗮𝘁𝗲 𝘁𝗵𝗲 𝗶𝗺𝗮𝗴𝗲𝘀. This means quicker results, greater accessibility, and reduced burden on healthcare professionals. 𝗪𝗶𝘁𝗵 𝗔𝗶𝗿𝗲𝗲𝗻, 𝘄𝗲’𝗿𝗲 𝗻𝗼𝘁 𝗷𝘂𝘀𝘁 𝗽𝗿𝗼𝘃𝗶𝗱𝗶𝗻𝗴 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆—𝘄𝗲’𝗿𝗲 𝗴𝗶𝘃𝗶𝗻𝗴 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝘁𝗲𝗮𝗺𝘀 𝘁𝗵𝗲 𝗽𝗼𝘄𝗲𝗿 to detect diabetic retinopathy early, prevent complications, and ultimately preserve sight for millions of people worldwide. 👁️ Innovating for better vision, every day. 👁️ #Aireen #DiabeticRetinopathy #HealthcareInnovation #EyeHealth #DigitalHealth #MondayMotivation #ImpactfulTechnology

We were thrilled to be part of the Innovation United 2024 conference, hosted by Startup Disrupt at the iconic Prague Castle. Over two dynamic days, we had the chance to showcase our innovative solutions and engage with an incredible group of forward-thinkers. Hearing how our product enhances patient experience and simplifies care for medical teams reassures us that we’re on the right path in shaping the future of healthcare. We're excited for the journey ahead! #InnovationUnited #StartupDisrupt #HealthcareTech #Aireen #PatientFirst #PragueCastle Jiří Kuchyňa Jan Hlaváček

Check-out our latest article to understand crucial classification differences! 𝗙𝗼𝗿 𝗔𝗶𝗿𝗲𝗲𝗻 𝗗𝗥, 𝗰𝗹𝗮𝘀𝘀𝗶𝗳𝗶𝗲𝗱 𝗮𝘀 𝗮 𝗖𝗹𝗮𝘀𝘀 𝗜𝗜𝗯 𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗱𝗲𝘃𝗶𝗰𝗲, 𝘁𝗵𝗲 𝗱𝗶𝘀𝘁𝗶𝗻𝗰𝘁𝗶𝗼𝗻 𝗯𝗲𝘁𝘄𝗲𝗲𝗻 𝗯𝗲𝗶𝗻𝗴 𝗮 𝗱𝗲𝗰𝗶𝘀𝗶𝗼𝗻-𝗺𝗮𝗸𝗲𝗿 𝘃𝗲𝗿𝘀𝘂𝘀 𝘀𝗶𝗺𝗽𝗹𝘆 𝗽𝗿𝗼𝘃𝗶𝗱𝗶𝗻𝗴 𝗱𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝗶𝘀 𝗶𝗺𝗽𝗼𝗿𝘁𝗮𝗻𝘁. But what does this mean for healthcare providers? 𝗗𝗼 𝘆𝗼𝘂 𝘂𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱 𝘁𝗵𝗲 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝗰𝗲𝘀 𝗯𝗲𝘁𝘄𝗲𝗲𝗻 𝗖𝗹𝗮𝘀𝘀 𝗜𝗜𝗮 𝗮𝗻𝗱 𝗖𝗹𝗮𝘀𝘀 𝗜𝗜𝗯 𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗱𝗲𝘃𝗶𝗰𝗲𝘀—𝗮𝗻𝗱 𝗵𝗼𝘄 𝘁𝗵𝗲𝘀𝗲 𝗰𝗹𝗮𝘀𝘀𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 𝗮𝗳𝗳𝗲𝗰𝘁 𝗿𝗲𝗮𝗹-𝗹𝗶𝗳𝗲 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗮𝗻𝗱 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗰𝗮𝗿𝗲? Discover the impact of AI-driven decision-making and why it’s important for diabetic retinopathy screening. Jan Hlaváček Jozefína Vaľková Matej Adam Jiří Kuchyňa Jan Bayer Martin Slíva David Navratil Adam Švrčina Aireen Václav Čermák #aireen #MDR #medicaldevice #AI #healthcare

𝗥𝗲𝗮𝗹-𝗪𝗼𝗿𝗹𝗱 𝗦𝘂𝗰𝗰𝗲𝘀𝘀: 𝗔𝗶𝗿𝗲𝗲𝗻’𝘀 𝗔𝗜-𝗣𝗼𝘄𝗲𝗿𝗲𝗱 𝗥𝗲𝘁𝗶𝗻𝗮𝗹 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗠𝗮𝗸𝗶𝗻𝗴 𝗮 𝗗𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗶𝗻 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗖𝗮𝗿𝗲 We are proud to share the real-world impact of Aireen’s AI technology in clinical settings, as highlighted by our valued clients. Prof. MUDr. Martin Prázný, CSc., Ph.D., Chairman of the Czech Diabetology Society, shared his experience: "𝘋𝘪𝘢𝘣𝘦𝘵𝘪𝘤 𝘳𝘦𝘵𝘪𝘯𝘰𝘱𝘢𝘵𝘩𝘺 𝘴𝘤𝘳𝘦𝘦𝘯𝘪𝘯𝘨 𝘪𝘯 𝘥𝘪𝘢𝘣𝘦𝘵𝘦𝘴 𝘰𝘶𝘵𝘱𝘢𝘵𝘪𝘦𝘯𝘵 𝘤𝘭𝘪𝘯𝘪𝘤𝘴 𝘦𝘯𝘢𝘣𝘭𝘦𝘥 𝘶𝘴 𝘵𝘰 𝘮𝘰𝘳𝘦 𝘦𝘧𝘧𝘪𝘤𝘪𝘦𝘯𝘵𝘭𝘺 𝘢𝘯𝘥 𝘲𝘶𝘪𝘤𝘬𝘭𝘺 𝘪𝘥𝘦𝘯𝘵𝘪𝘧𝘺 𝘱𝘢𝘵𝘪𝘦𝘯𝘵𝘴 𝘢𝘵 𝘳𝘪𝘴𝘬 𝘰𝘧 𝘦𝘺𝘦 𝘤𝘰𝘮𝘱𝘭𝘪𝘤𝘢𝘵𝘪𝘰𝘯𝘴. 𝘞𝘦 𝘤𝘢𝘯 𝘢𝘭𝘳𝘦𝘢𝘥𝘺 𝘴𝘦𝘦 𝘵𝘩𝘦 𝘳𝘦𝘴𝘶𝘭𝘵𝘴 𝘰𝘧 𝘵𝘩𝘪𝘴 𝘴𝘪𝘨𝘯𝘪𝘧𝘪𝘤𝘢𝘯𝘵 𝘪𝘮𝘱𝘳𝘰𝘷𝘦𝘮𝘦𝘯𝘵 𝘪𝘯 𝘵𝘩𝘦 𝘤𝘢𝘳𝘦 𝘰𝘧 𝘰𝘶𝘳 𝘱𝘢𝘵𝘪𝘦𝘯𝘵𝘴, 𝘢𝘯𝘥 𝘵𝘩𝘦 𝘪𝘯𝘤𝘪𝘥𝘦𝘯𝘤𝘦 𝘰𝘧 𝘢𝘥𝘷𝘢𝘯𝘤𝘦𝘥 𝘧𝘰𝘳𝘮𝘴 𝘰𝘧 𝘥𝘪𝘢𝘣𝘦𝘵𝘪𝘤 𝘳𝘦𝘵𝘪𝘯𝘰𝘱𝘢𝘵𝘩𝘺 𝘸𝘪𝘭𝘭 𝘤𝘰𝘯𝘵𝘪𝘯𝘶𝘦 𝘵𝘰 𝘥𝘦𝘤𝘳𝘦𝘢𝘴𝘦 𝘵𝘩𝘢𝘯𝘬𝘴 𝘵𝘰 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘷𝘦 𝘤𝘢𝘳𝘦. 𝘐 𝘢𝘱𝘱𝘳𝘦𝘤𝘪𝘢𝘵𝘦 𝘵𝘩𝘦 𝘢𝘥𝘷𝘢𝘯𝘤𝘦𝘥 𝘵𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘺 𝘢𝘯𝘥 𝘳𝘦𝘭𝘪𝘢𝘣𝘪𝘭𝘪𝘵𝘺 𝘈𝘪𝘳𝘦𝘦𝘯 𝘣𝘳𝘪𝘯𝘨𝘴 𝘵𝘰 𝘰𝘶𝘳 𝘱𝘳𝘢𝘤𝘵𝘪𝘤𝘦." Additionally, diabetologist MUDr. Vojtěch Sigl, one of the many clients, expressed his satisfaction: "𝘐 𝘤𝘩𝘰𝘴𝘦 𝘵𝘩𝘦 𝘧𝘶𝘯𝘥𝘶𝘴 𝘤𝘢𝘮𝘦𝘳𝘢 𝘢𝘧𝘵𝘦𝘳 𝘤𝘰𝘮𝘱𝘢𝘳𝘪𝘯𝘨 𝘰𝘱𝘵𝘪𝘰𝘯𝘴 𝘢𝘵 𝘢 𝘥𝘪𝘢𝘣𝘦𝘵𝘦𝘴 𝘴𝘦𝘮𝘪𝘯𝘢𝘳 𝘪𝘯 𝘗𝘳𝘢𝘨𝘶𝘦 𝘢𝘯𝘥 𝘐 𝘢𝘱𝘱𝘳𝘦𝘤𝘪𝘢𝘵𝘦𝘥 𝘈𝘪𝘳𝘦𝘦𝘯 𝘋𝘙 𝘴𝘰𝘧𝘵𝘸𝘢𝘳𝘦. 𝘐 𝘱𝘳𝘪𝘮𝘢𝘳𝘪𝘭𝘺 𝘱𝘩𝘰𝘵𝘰𝘨𝘳𝘢𝘱𝘩 𝘱𝘢𝘵𝘪𝘦𝘯𝘵𝘴 𝘸𝘩𝘰 𝘥𝘰 𝘯𝘰𝘵 𝘨𝘰 𝘧𝘰𝘳 𝘳𝘦𝘨𝘶𝘭𝘢𝘳 𝘦𝘺𝘦 𝘦𝘹𝘢𝘮𝘪𝘯𝘢𝘵𝘪𝘰𝘯𝘴, 𝘢𝘯𝘥 𝘐 𝘳𝘦𝘧𝘦𝘳 𝘵𝘩𝘰𝘴𝘦 𝘪𝘯 𝘸𝘩𝘰𝘮 𝘐 𝘥𝘦𝘵𝘦𝘤𝘵 𝘴𝘪𝘨𝘯𝘴 𝘰𝘧 𝘥𝘪𝘢𝘣𝘦𝘵𝘪𝘤 𝘳𝘦𝘵𝘪𝘯𝘰𝘱𝘢𝘵𝘩𝘺 𝘵𝘰 𝘢𝘯 𝘰𝘱𝘩𝘵𝘩𝘢𝘭𝘮𝘰𝘭𝘰𝘨𝘪𝘴𝘵. 𝘐 𝘢𝘮 𝘷𝘦𝘳𝘺 𝘩𝘢𝘱𝘱𝘺 𝘸𝘪𝘵𝘩 𝘵𝘩𝘦 𝘱𝘳𝘰𝘥𝘶𝘤𝘵 𝘢𝘯𝘥 𝘵𝘩𝘦 𝘳𝘦𝘤𝘦𝘯𝘵 𝘶𝘱𝘥𝘢𝘵𝘦 𝘮𝘢𝘥𝘦 𝘮𝘺 𝘸𝘰𝘳𝘬 𝘮𝘶𝘤𝘩 𝘧𝘢𝘴𝘵𝘦𝘳." These testimonials underscore the tangible benefits of Aireen’s solutions, from improving patient outcomes to enhancing the efficiency of diabetes care. We are committed to continuing our work in transforming healthcare with reliable, cutting-edge technology. #AI #HealthcareInnovation #RetinalDiagnostics #DiabetesCare #AIDiagnostics

The Aireen team is thrilled to announce that we’ll be at ESCRS 2024 in Barcelona, starting on the 6th of September! We're excited to showcase our latest advancements in AI-powered retinal diagnostics and discuss how we’re transforming healthcare with scalable solutions. Whether you're interested in partnerships, investment opportunities, or just want to learn more about our innovative technology, we’d love to connect. Schedule a meeting by contacting Adam Svrcina here on LinkedIn or by sending an email to adam.svrcina@aireen.com . #ESCRS2024 #Barcelona #HealthcareInnovation #AIDiagnostics #RetinalImaging

AIRE

COM:AIREEN

Aireen

locale

market

industry

website

crunchbase

linkedin

competitor of

Metrics